These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 16770097

  • 1. [Clinical study of 5-Fluorouracil and l-Leucovorin therapy for 56 patients with advanced recurrent colorectal carcinoma].
    Matsuda T, Ogino K, Hiroyoshi M, Fujita H, Itoh T, Toyama H, Kawai Y, Makita D, Tsunemi K, Moritomo H, Nakamura T.
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):783-7. PubMed ID: 16770097
    [Abstract] [Full Text] [Related]

  • 2. [Clinical study of ambulatory cancer chemotherapy for advanced colorectal cancer].
    Takahashi N, Kunii Y, Ota K.
    Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():447-52. PubMed ID: 8849291
    [Abstract] [Full Text] [Related]

  • 3. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.
    Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, Cardaci G, Gray B.
    J Surg Oncol; 2004 Nov 01; 88(2):78-85. PubMed ID: 15499601
    [Abstract] [Full Text] [Related]

  • 4. [Retrospective analysis on efficacy and toxicity of 5-fluorouracil (5-FU) and l-leucovorin (l-LV) in advanced or recurrent colorectal cancer].
    Chiba N, Yoshioka T, Kato S, Takahashi S, Shibata H, Kato S, Sakayori M, Otsuka K, Kakudo Y, Ohori H, Yamaura G, Takahashi M, Yasuda K, Ishioka C.
    Gan To Kagaku Ryoho; 2005 Jul 01; 32(7):991-5. PubMed ID: 16044961
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamaguchi Y, Hasuike N, Yamazaki K, Machida N, Ono H.
    Jpn J Clin Oncol; 2007 Sep 01; 37(9):686-91. PubMed ID: 17720736
    [Abstract] [Full Text] [Related]

  • 6. [Clinical administration of FOLFOX regimens for patients with unresectable advanced or recurrent colorectal cancer].
    Minami K, Kameda A, Tsutani Y, Suzuki T, Miyahara E, Noso Y.
    Gan To Kagaku Ryoho; 2007 Apr 01; 34(4):573-7. PubMed ID: 17431362
    [Abstract] [Full Text] [Related]

  • 7. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
    Shitara K, Munakata M, Muto O, Kasai M, Okada R, Mitobe S, Sakata Y.
    Gan To Kagaku Ryoho; 2007 Jul 01; 34(7):1079-84. PubMed ID: 17637544
    [Abstract] [Full Text] [Related]

  • 8. First-line chemotherapy with low-dose leucovorin plus 5-fluorouracil (LV/5-FU) for elderly patients with metastatic colorectal cancer.
    Yoshimatsu K, Yokomizo H, Fujimoto T, Umehara A, Otani T, Matsumoto A, Osawa G, Shiozawa S, Katsube T, Naritaka Y, Ogawa K.
    Anticancer Res; 2007 Jul 01; 27(3B):1641-4. PubMed ID: 17595789
    [Abstract] [Full Text] [Related]

  • 9. A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer.
    Xiong JP, Zhang L, Zhong LX, Qiu F, Xu J, Tao QS, Xiang XJ, Yu F, Tang XM.
    Anticancer Drugs; 2007 Oct 01; 18(9):1103-7. PubMed ID: 17704661
    [Abstract] [Full Text] [Related]

  • 10. [5-Fluorouracil plus low-dose leucovorin in the treatment of advanced colorectal cancer].
    Shida H, Ban K, Matsumoto M, Takei Y, Noda Y, Masuda K, Imanari T, Machida T, Yamamoto T.
    Gan To Kagaku Ryoho; 1994 Feb 01; 21(2):249-54. PubMed ID: 8311497
    [Abstract] [Full Text] [Related]

  • 11. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer.
    Kundel Y, Purim O, Figer A, Stemmer SM, Tichler T, Sulkes J, Sulkes A, Brenner B.
    Med Sci Monit; 2008 Apr 01; 14(4):CR190-5. PubMed ID: 18376346
    [Abstract] [Full Text] [Related]

  • 12. [Treatment for advanced colorectal carcinoma with 5-fluorouracil plus low-dose leucovorin].
    Asato Y, Yoshimi F, Ono H, Amemiya R, Koizumi S, Hasegawa H, Miya T, Goya T.
    Gan To Kagaku Ryoho; 1999 Jun 01; 26(7):945-50. PubMed ID: 10396322
    [Abstract] [Full Text] [Related]

  • 13. [Clinical study of ambulatory patient cancer chemotherapy for advanced colorectal cancer].
    Toyokawa A, Tsujimura T, Hamabe Y, Sato S, Mukubou H, Wakahara T, Kaji M, Tsukamoto T, Wakita K, Onishi N, Ishida T, Watanabe A, Fujiwara H, Mukai H.
    Gan To Kagaku Ryoho; 2005 Dec 01; 32(13):2087-90. PubMed ID: 16352933
    [Abstract] [Full Text] [Related]

  • 14. A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer.
    Oh SY, Kwon HC, Seo BG, Kim SH, Kim JS, Kim HJ.
    Acta Oncol; 2007 Dec 01; 46(3):336-41. PubMed ID: 17450469
    [Abstract] [Full Text] [Related]

  • 15. [An institution-randomized trial of 5-fluorouracil and l-leucovorin therapy given monthly versus every two months to patients with advanced colorectal carcinoma].
    Hasegawa S, Akaike M, Yamamoto Y, Shiraishi R, Ozawa Y, Suzuki H, Miyazaki T, Kasahara A, Makino T, Tamura I, Tanabe H, Rino Y.
    Gan To Kagaku Ryoho; 2004 May 01; 31(5):729-33. PubMed ID: 15170981
    [Abstract] [Full Text] [Related]

  • 16. A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.
    Viel E, Demarchi MF, Chaigneau L, Nguyen T, Legat C, Stein U, Thiery-Vuillemin A, Limat S, Pivot X, Borg C.
    Am J Clin Oncol; 2008 Feb 01; 31(1):89-94. PubMed ID: 18376234
    [Abstract] [Full Text] [Related]

  • 17. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
    Matsushita H, Tsuboi K, Honda I, Kato N, Okochi O, Kobayashi D, Hattori M.
    Gan To Kagaku Ryoho; 2009 May 01; 36(5):797-801. PubMed ID: 19461180
    [Abstract] [Full Text] [Related]

  • 18. [Results of hepatic arterial infusion chemotherapy with 5-FU and leucovorin for unresectable liver metastases from colorectal cancer].
    Yamashita K, Urakami A, Kubota H, Nagatsuka R, Murakami H, Kawabe Y, Higashida M, Hirabayashi Y, Mikami Y, Ikeda M, Fuchimoto M, Yamamura M, Oka Y, Okumura H, Iki K, Matsumoto H, Imai S, Hirai T, Tsunoda T.
    Gan To Kagaku Ryoho; 2008 Jan 01; 35(1):71-6. PubMed ID: 18195531
    [Abstract] [Full Text] [Related]

  • 19. A phase i study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel (FLTAX) as first-line therapy for advanced gastric cancer.
    Matsubara J, Shimada Y, Takashima A, Takahari D, Hirashima Y, Okita NT, Nakajima TE, Kato K, Hamaguchi T, Yamada Y, Shirao K.
    Jpn J Clin Oncol; 2008 Aug 01; 38(8):540-6. PubMed ID: 18628316
    [Abstract] [Full Text] [Related]

  • 20. Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer.
    Lin PC, Chen WS, Chao TC, Yang SH, Tiu CM, Liu JH.
    Cancer Chemother Pharmacol; 2007 Aug 01; 60(3):351-6. PubMed ID: 17111120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.